Diarrhoea for the Acute Physician

Similar documents
Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Management of the Hospitalized IBD Patient. Drew DuPont MD

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn s Disease. Resident Lecture 1/17/19

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

The London Gastroenterology Partnership CROHN S DISEASE

Indications for use of Infliximab

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Από τη θεωρία στη πράξη: Συζήτηση κλινικών περιστατικών. Κωνσταντίνος Κατσάνος Επίκουρος Καθηγητής Γαστρεντερολογίας Πανεπιστήμιο Ιωαννίνων

Algorithm for managing severe ulcerative colitis

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D.

INFLAMMATORY BOWEL DISEASE

Crohn's Disease. The What, When, and Why of Treatment

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board

Slide 1 Medications in inflammatory bowel disease a primer for health care providers. Slide 2. Slide 3 Theory of pathogenesis. IBD - epidemiology

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

Clinical guideline Published: 10 October 2012 nice.org.uk/guidance/cg152

Ali Keshavarzian MD Rush University Medical Center

Trust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over)

Doncaster & Bassetlaw Medicines Formulary

What is Crohn's disease?

An Unusual Complication of Crohn s Disease. Dr Gerald Busuttil Mr Debono s Firm Surgical Grand Round 25 th November 2008

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

Biologics in IBD. Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College

PEDIATRIC INFLAMMATORY BOWEL DISEASE

A Case of Inflammatory Bowel Disease

What do we need for diagnosis of IBD

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego

What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff

Disclosure of Affiliations. The Way We Hope It Goes. Medicines and Surgery for IBD. None. Cases: Sweet and Not So Sweet

Implementation of disease and safety predictors during disease management in UC

Achieving Success in Ulcerative Colitis: the Role of Infliximab

IBD in teenagers Biological and Transition

Update on IBD. Dr Richard POLLOK Consultant Gastroenterologist and Honorary Senior Lecturer. Queen Mary s Hospital. St George s Hospital

Which is the Safest Strategy to Treat Moderate to Severe IBD?

Diarrhoea on the AMU. Dr Chris Roseveare

Treating Crohn s and Colitis in the ASC

CASE STUDY: ULCERATIVE COLITIS. Sammi Montag Dietetic Intern

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

To help protect your privacy, PowerPoint prevented this external picture from being automatically downloaded. To download and display this picture,

September 12, 2015 Millie D. Long MD, MPH, FACG

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

Efficacy and Safety of Treatment for Pediatric IBD

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD

ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה

Nutrition as primary therapy in IBD. Dr Clare Donnellan Leeds General Infirmary

Dr David Rowbotham. The Leeds Teaching Hospitals NHS Trust NHS

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018

Fistulizing Crohn s Disease: The Aggressive Approach

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

Perianal and Fistulizing Crohn s Disease: Tough Management Decisions. Jean-Paul Achkar, M.D. Kenneth Rainin Chair for IBD Research Cleveland Clinic

Efficacy and Safety of Treatment for Pediatric IBD

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

PIBD03 - Page 1 of June-03

INFLAMMATORY BOWEL DISEASE

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

Anti-TNF and cyclosporine are identical choices for severe ulcerative colitis refractory to steroid therapy CON Peter Laszlo LAKATOS Semmelweis

Case Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Medical Therapy for Pediatric IBD: Efficacy and Safety

CHRONIC DIARRHEA DR. PHILIP K. BLUSTEIN M.D. F.R.C.P.(C) DEFINITION: *LOOSE, WATERY STOOLS *MORE THAN 3 TIMES A DAY *FOR MORE THAN 4 WEEKS

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Surgery in Inflammatory Bowel Disease. Rajesh Gupta MS, MCh Surgical Gastroenterology Division Dept of General Surgery PGIMER, Chandigarh

OUNCE OF PREVENTION WORTH A POUND OF CURE

TYSABRI FOR CROHN S DISEASE

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Paediatric Gastroenterology Clinical Network. Management of Inflammatory Bowel Disease in Children and Adolescents in New Zealand

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente

CCFA. Crohns Disease vs UC: What is the best treatment for me? November

Crohn's Disease. The What, When, and Why of Treatment

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

The ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012

Protocol for the management of acute severe ulcerative colitis in children

Managing. Inflammatory Bowel Disease. Slide 1. Slide 2. Slide 3. Disclosures. Vijay Yajnik, MD., PhD 01/25/14. None relevant to this talk

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY

Inflammatory Bowel Disease and Surgery: What You Should Know

Identifying and Managing Patients with IBD at Risk for Progressive Disease

P a g e 1. Inflammatory Bowel Disease Guidelines

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012

Understanding Inflammatory Bowel Diseases (IBD):

How to manage your IBD patient: Tips for diagnosis and care

Crohn's Disease. The What, When, and Why of Treatment

Transcription:

Diarrhoea for the Acute Physician STEPHEN INNS GASTROENTEROLOGIST AND PHYSICIAN HUTT VALLEY DHB August 2013 Outline Case History 1 Initial assessment of acute diarrhoea Management of fulminant UC Management of acute Crohns disease Diarrhoea in the elderly: C. difficile Patient with diarrhoea Seven times per day, twice at night Diffuse abdominal pain and tenderness What is the differential diagnosis?

Initial Assessment Rigid Sigmoidoscopy Demographics Duration Vomiting Nature of diarrhoea Watery vs inflammatory vs fatty Stool microscopy Prolonged, severe or bloody diarrhoea Stool C. diff, OCP, culture Routine bloods Rigid sigmoidoscopy and biopsy AXR http://emedicine.medscape.com/article/81001- media Investigation of Inflammatory Diarrhoea Investigation of Secretory Diarrhoea Most first presentations will be infection Followed by IBD and ischaemia AXR in all Decision to proceed depends on clinical state Red blood in diarrhoea Proctoscopy and/or flexible sigmoidoscopy R sided/small bowel pain or tenderness; malabsorption Small bowel CT and ileo-colonoscopy Most first presentations will be infection Followed by IBD and ischaemia Coeliac antibodies, careful drug history Decision to proceed depends on chronicity and severity Ileocolonoscopy and biopsy (microscopic colitis) CT enteroclysis Antibiotics in Acute Diarrhoea Case History 1 Empiric use in traveller s diarrhoea Fluoroquinolone, ultrashort course If dysentery (infectious bloody diarrhoea) suspected and amoebae, EHEC, STEC ruled out Fluoroquinolone 3-5 days awaiting culture 35 year old male patient with diarrhoea 2 weeks, gradual onset Seven times per day, twice at night Diffuse abdominal pain and tenderness Red blood and mucus in stool Febrile 37.8C, HR 95/min, ESR 35, Hb 100

ASSESSING SEVERITY OF UC (Truelove & Witts BMJ 1954) stools mild <5/d, trace blood severe >5/d, bloody What is the severity of this colitis? temperature pulse Hb ESR No fever >37.8 <90 >90 Normal <10.5 <30 >30 Daily CRP to monitor response Fulminant colitis mortality reduced from 50% - 1.5% Case History Meticulous clinical care Multidisciplinary approach IV hydrocortisone 100mg qds (60%) Prophylaxis against DVT/PE Cyclosporin 2mg/kg (levels 150-250) 60% initial response, 30% long term Continue steroids, Azathioprine on discharge, PCP prophylaxis Monitor Mg, Cholesterol Biologicals: infliximab 5 mg/kg IV 3 month colectomy rate (7/24) vs. placebo (14/21) Symptomatic remission after IV hydrocortisone BO x 3/day semiformed no blood Corticosteroids in IBD Problems With Steroids Restrict to active IBD Co-prescribe bone protection No prophylactic role Minimise long-term use 65% remission/improvement in 4/12 Given inappropriately Recurrence after stopping Side-effects Failure to heal mucosa

60% remission OR 2.0 cf placebo in meta-analysis Dose dependant Renal toxicity Dose dependant nephritis Class effect 5 ASA for acute UC Case history 2 16 yo male patient with bloody diarrhoea Seven times per day, twice at night Diffuse abdominal pain and tenderness, concentrated in RIF Examination T 38, pale, thin, short, BMI = 16, prepubertal, tender mass RIF Colonoscopy - extensive patchy colitis and terminal ileal involvement US no collection but mass of thickened loops of bowel in RIF Ba follow through - 30 cm of affected ileum CD Activity Scores Harvey-Bradshaw index: General well-being (0 = very well, 1 = slightly below par, 2 = poor, 3 = very poor, 4 = terrible). Abdominal pain (0 = none, 1 = mild, 2 = moderate, 3 = severe). Number of liquid stools per day. Abdominal mass (0 = none, 1 = dubious, 2 = definite, 3 = definite and tender). Complications: arthralgia, uveitis, erythema nodosum, aphthous ulcers, pyoderma gangrenosum, anal fissure, new fistula, abscess (score 1 per item). Case History - what options? 5-ASA Steroids Elemental / polymeric diet Prolonged oral antibiotics Immunosuppression Azathioprine, Methotrexate Stop smoking Infliximab Colectomy + ileostomy +/- IRA Experimental immunological Rx / thalidomide Case History - what options? 5-ASA Steroids Elemental / polymeric diet Prolonged oral antibiotics Immunosuppression Azathioprine, Methotrexate Stop smoking Infliximab/Adalimumab Colectomy + ileostomy +/- IRA Experimental immunological Rx / thalidomide

Steroids in Crohn s disease Azathioprine for remission induction in Crohn s disease Gut, 1994; 35: 360 >17 weeks to have full effect Benefit at 2.5mg/kg but not much beyond Methotrexate in Crohn s disease 141 patients 2:1 25mg im weekly MTX for 16 weeks 20 mg steroid at day 1 and taper N Engl J Med. 1995 Feb 2;332(5):292-7 Methotrexate in Crohn s disease - maintenance Case history Started on azathioprine 2mg/kg after TPMT (normal), tolerates OK Can t tolerate steroids with neuropsychiatric side effects Still not well after 3 weeks despite dietary therapy - pain, diarrhoea Develops perianal soreness and leaking fistula BMI 18, Hb 8.9, Alb 21, CRP 35 What next?

Healing With Anti-TNFalpha Antibodies Results Chronic active 30% remission 30% improvement Fistulation 40% closure Pretreatment 4 Weeks Post treatment Van Dullemen Gastroenterology 1995 Early recurrence on stopping Maintenance treatment essential General Contra-indications AntiTNF: Side-effects Intestinal sepsis pregnancy, lactation (experience reassuring) infection, esp TB heart failure malignancy infusion reactions acute 20% delayed hypersensitivity 2% ANA - 50% dsdna Abs lymphoma? heart failure demyelination, aseptic meningitis infections Paradoxical inflammation!!cost - $10000-30000 per year!! Case History Induction of clinical remission of luminal and perianal disease at 3 months Acute Diarrhoea in the Elderly

Case History 1 Clostridium difficile is a Disease of the Elderly 80 year old female patient with diarrhoea for one week Seven times per day, twice at night Diffuse abdominal pain and tenderness Omeprazole for longstanding non-ulcer dyspepsia 7 days Augmentin 3 weeks ago, infected leg ulcers Past TIA and NSTEMI with PVD What is the differential diagnosis? Testing HVDHB Glutamate dehydrogenase If positive toxin PCR (NAAT) CCDHB GDH If positive Elisa for toxin A&B No serial testing Don t test for cure Odds ratio of C. difficile with PPI 2.5 Vancomycin treatment of choice in severe infection Severe Clostridium difficile Pseudomembranous colitis on endoscopy admission to an intensive care unit or any two of the following factors: an age of more than 60 years temperature above 38.3 C serum albumin less than 25 g/l white-cell count of more than 15x10 9 /L (acute renal failure)

Summary Clinical features dictate the investigative approach Multidisciplinary approach and attention to detail saves lives in fulminant colitis Useful tools to assess severity and guide therapy Steroids temporary option in IBD, always accompanied by bony prophylaxis Biologics available but not a panacea Vancomycin as first line with early surgical assessment for severe CD Questions